Skye Bioscience
As of the edition of 20 October 2026, Skye Bioscience runs 1 drug.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
- Bird Rock Bio, Inc.: acquired in 2023; successor Skye Bioscience, Inc.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
Where its trials are
- Digestive system: 2 trials led
- Nutrition and metabolism: 1 trials led